• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

机器学习模型在预测幽门螺杆菌根除后胃癌风险中的应用。

Applications of machine learning models in the prediction of gastric cancer risk in patients after Helicobacter pylori eradication.

机构信息

Department of Medicine, University of Hong Kong, Hong Kong, China.

Department of Surgery, University of Hong Kong, Hong Kong, China.

出版信息

Aliment Pharmacol Ther. 2021 Apr;53(8):864-872. doi: 10.1111/apt.16272. Epub 2021 Jan 24.

DOI:10.1111/apt.16272
PMID:33486805
Abstract

BACKGROUND

The risk of gastric cancer after Helicobacter pylori (H. pylori) eradication remains unknown.

AIM

To evaluate the performances of seven different machine learning models in predicting gastric cancer risk after H. pylori eradication.

METHODS

We identified H. pylori-infected patients who had received clarithromycin-based triple therapy between 2003 and 2014 in Hong Kong. Patients were divided into training (n = 64 238) and validation sets (n = 25 330), according to period of eradication therapy. The data were used to construct seven machine learning models to predict risk of gastric cancer development within 5 years after H. pylori eradication. A total of 26 clinical variables were input into these models. The performances were measured by the area under receiver operating characteristic curve (AUC) analysis.

RESULTS

During a mean follow-up of 4.7 years, 0.21% of H. pylori-eradicated patients developed gastric cancer. Of the seven machine learning models, extreme gradient boosting (XGBoost) had the best performance in predicting cancer development (AUC 0.97, 95%CI 0.96-0.98), and was superior to conventional logistic regression (AUC 0.90, 95% CI 0.84-0.92). With the XGBoost model, the number of patients considered at high risk of gastric cancer was 6.6%, with miss rate of 1.9%. Patient age, presence of intestinal metaplasia, and gastric ulcer were the heavily weighted factors used by the XGBoost.

CONCLUSION

Based on simple baseline patient information, machine learning model can accurately predict the risk of post-eradication gastric cancer. This model could substantially reduce the number of patients who require endoscopic surveillance.

摘要

背景

幽门螺杆菌(H. pylori)根除后胃癌的风险尚不清楚。

目的

评估七种不同机器学习模型在预测 H. pylori 根除后胃癌风险中的表现。

方法

我们在香港确定了 2003 年至 2014 年间接受克拉霉素三联疗法治疗的 H. pylori 感染患者。根据根除治疗的时间,患者被分为训练集(n=64238)和验证集(n=25330)。使用这些数据构建了七种机器学习模型,以预测 H. pylori 根除后 5 年内胃癌发展的风险。总共输入了 26 个临床变量到这些模型中。通过接受者操作特征曲线(ROC)下面积(AUC)分析来衡量性能。

结果

在平均 4.7 年的随访中,0.21%的 H. pylori 根除患者发生了胃癌。在七种机器学习模型中,极端梯度提升(XGBoost)在预测癌症发展方面表现最佳(AUC 0.97,95%CI 0.96-0.98),优于传统的逻辑回归(AUC 0.90,95%CI 0.84-0.92)。使用 XGBoost 模型,有 6.6%的患者被认为患有胃癌的风险较高,漏诊率为 1.9%。患者年龄、肠化生存在和胃溃疡是 XGBoost 中使用的重要因素。

结论

基于简单的基线患者信息,机器学习模型可以准确预测根除后胃癌的风险。该模型可以大大减少需要内镜监测的患者数量。

相似文献

1
Applications of machine learning models in the prediction of gastric cancer risk in patients after Helicobacter pylori eradication.机器学习模型在预测幽门螺杆菌根除后胃癌风险中的应用。
Aliment Pharmacol Ther. 2021 Apr;53(8):864-872. doi: 10.1111/apt.16272. Epub 2021 Jan 24.
2
Effects of Helicobacter pylori Treatment on Incidence of Gastric Cancer in Older Individuals.幽门螺杆菌治疗对老年人胃癌发病率的影响。
Gastroenterology. 2018 Jul;155(1):67-75. doi: 10.1053/j.gastro.2018.03.028. Epub 2018 Mar 14.
3
Baseline gastric mucosal atrophy is a risk factor associated with the development of gastric cancer after Helicobacter pylori eradication therapy in patients with peptic ulcer diseases.基线胃黏膜萎缩是消化性溃疡疾病患者幽门螺杆菌根除治疗后发生胃癌的一个相关危险因素。
J Gastroenterol. 2007 Jan;42 Suppl 17:21-7. doi: 10.1007/s00535-006-1924-9.
4
Statins Were Associated with a Reduced Gastric Cancer Risk in Patients with Eradicated Infection: A Territory-Wide Propensity Score Matched Study.他汀类药物与根除 感染患者的胃癌风险降低相关:一项全港范围的倾向评分匹配研究。
Cancer Epidemiol Biomarkers Prev. 2020 Feb;29(2):493-499. doi: 10.1158/1055-9965.EPI-19-1044. Epub 2019 Dec 2.
5
Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.幽门螺杆菌根除与胃癌发病率的关系:系统评价和荟萃分析。
Gastroenterology. 2016 May;150(5):1113-1124.e5. doi: 10.1053/j.gastro.2016.01.028. Epub 2016 Feb 2.
6
Effect of Helicobacter pylori eradication on metachronous recurrence after endoscopic resection of gastric neoplasm.幽门螺杆菌根除对胃肿瘤内镜切除后异时性复发的影响。
Am J Gastroenterol. 2014 Jan;109(1):60-7. doi: 10.1038/ajg.2013.404. Epub 2013 Dec 17.
7
Histologic intestinal metaplasia and endoscopic atrophy are predictors of gastric cancer development after Helicobacter pylori eradication.组织学肠化生和内镜下萎缩是幽门螺杆菌根除后胃癌发展的预测因素。
Gastrointest Endosc. 2016 Oct;84(4):618-24. doi: 10.1016/j.gie.2016.03.791. Epub 2016 Mar 16.
8
Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial.在中国高危地区根除幽门螺杆菌预防胃癌:一项随机对照试验。
JAMA. 2004 Jan 14;291(2):187-94. doi: 10.1001/jama.291.2.187.
9
Helicobacter pylori eradication and gastric cancer: when is the horse out of the barn?幽门螺杆菌根除与胃癌:马何时已出厩?
Am J Gastroenterol. 2009 Jun;104(6):1342-5. doi: 10.1038/ajg.2008.15.
10
Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer.系统评价:根除幽门螺杆菌预防胃癌
Aliment Pharmacol Ther. 2007 Jan 15;25(2):133-41. doi: 10.1111/j.1365-2036.2006.03183.x.

引用本文的文献

1
First regional consensus on the management of infection in the Middle East.中东地区关于感染管理的首个区域共识。
World J Gastroenterol. 2025 Jul 21;31(27):107138. doi: 10.3748/wjg.v31.i27.107138.
2
The artificial intelligence revolution in gastric cancer management: clinical applications.胃癌管理中的人工智能革命:临床应用
Cancer Cell Int. 2025 Mar 21;25(1):111. doi: 10.1186/s12935-025-03756-4.
3
Application of Machine Learning in the Diagnosis of Early Gastric Cancer Using the Kyoto Classification Score and Clinical Features Collected from Medical Consultations.
利用京都分类评分和医疗咨询收集的临床特征,将机器学习应用于早期胃癌的诊断
Bioengineering (Basel). 2024 Sep 27;11(10):973. doi: 10.3390/bioengineering11100973.
4
Screening of gastric cancer diagnostic biomarkers in the homologous recombination signaling pathway and assessment of their clinical and radiomic correlations.同源重组信号通路中胃癌诊断生物标志物的筛选及其临床和放射组学相关性评估。
Cancer Med. 2024 Aug;13(16):e70153. doi: 10.1002/cam4.70153.
5
A Machine Learning Method for Differentiation Crohn's Disease and Intestinal Tuberculosis.一种用于区分克罗恩病和肠结核的机器学习方法。
J Multidiscip Healthc. 2024 Aug 8;17:3835-3847. doi: 10.2147/JMDH.S470429. eCollection 2024.
6
Machine Learning-Based Prediction of Helicobacter pylori Infection Study in Adults.基于机器学习的成人幽门螺杆菌感染预测研究。
Med Sci Monit. 2024 Jun 8;30:e943666. doi: 10.12659/MSM.943666.
7
Hotspots and trends of risk factors in gastric cancer: A visualization and bibliometric analysis.胃癌危险因素的热点与趋势:可视化与文献计量分析
World J Gastrointest Oncol. 2024 May 15;16(5):2200-2218. doi: 10.4251/wjgo.v16.i5.2200.
8
Predicting early gastric cancer risk using machine learning: A population-based retrospective study.利用机器学习预测早期胃癌风险:一项基于人群的回顾性研究。
Digit Health. 2024 Mar 22;10:20552076241240905. doi: 10.1177/20552076241240905. eCollection 2024 Jan-Dec.
9
Application of Machine Learning Based on Structured Medical Data in Gastroenterology.基于结构化医学数据的机器学习在胃肠病学中的应用
Biomimetics (Basel). 2023 Oct 28;8(7):512. doi: 10.3390/biomimetics8070512.
10
Gut mycobiome as a potential non-invasive tool in early detection of lung adenocarcinoma: a cross-sectional study.肠道菌作为一种潜在的非侵入性工具在肺腺癌早期检测中的应用:一项横断面研究。
BMC Med. 2023 Oct 31;21(1):409. doi: 10.1186/s12916-023-03095-z.